Literature DB >> 8101820

Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in nonhuman primates.

J R Sladek1, J D Elsworth, R H Roth, L E Evans, T J Collier, S J Cooper, J R Taylor, D E Redmond.   

Abstract

Mesencephalic tissue containing newly generated dopamine neurons was collected from brains of embryonic African green monkeys at 44 and 49 days of gestation and stereotaxically implanted into multiple sites in the caudate nucleus of adult monkeys previously treated with the dopamine protoxin, 1-methyl-4-phenyl-1,2,3,6-tetrathydropyridine. Ultrasonography was utilized to assess the developmental stage prior to hysterotomy. Brains were removed for combined histochemical and biochemical analyses at 3 1/2 months after grafting to determine the extent of graft survival and growth. The dopamine content of the target nucleus was assessed from microdissected "punches" placed in proximity to grafts identified in unfixed brain slices prior to fixation. Tissue dopamine levels adjacent to the grafts were elevated markedly, reaching 25-50% of control levels at some sites in the caudate nucleus. Morphometric analysis of graft size and dopamine cell numbers was performed with computer-enhanced, video-based imaging. Exceptionally large grafts that far exceeded their initial size at the time of implantation were seen at each placement site. The dopamine cell count was as high as 3500 in a single graft from E44 tissue, but only as high as 550 from the E49 donor. Up to 15,000 tyrosine hydroxylase-positive neurons were stained in the host monkey that received E44 tissue; only 1/10 as many were seen in each of the recipients of E49 day samples. The earlier donor grafts occupied as much as 15% of the caudate nucleus as seen in a single coronal section; summation of all sections that contained grafts at each placement from the E44 donor revealed average areas occupied by the grafts ranging from 3 to 8% of the caudate nucleus. In comparison, grafts produced from an E49 donor averaged between 2.4 and 5.4% of the area of the target. Qualitatively, grafts from each gestational stage showed well-developed dopamine neurons with morphological characteristics equivalent to those of all three ventral mesencephalic dopamine cell groups. The attainment of large, well-differentiated grafts with thousands of dopaminergic neurons from early gestation tissue suggests that optimal cell survival in primates is dependent on the degree of postgerminal development of the dopamine neuron. Neurite extension may be critical in this regard as well as other, at present, undefined factors. Maximal graft development and cell survival may be a critical element in the ability of neural grafts to reverse a neurological disability and to maintain improvement in the event of continued degeneration of host dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101820     DOI: 10.1006/exnr.1993.1103

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age.

Authors:  E M Torres; C Monville; P R Lowenstein; M G Castro; S B Dunnett
Journal:  Brain Res Bull       Date:  2005-09-26       Impact factor: 4.077

2.  Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons.

Authors:  C Spenger; N S Haque; L Studer; L Evtouchenko; B Wagner; B Bühler; U Lendahl; S B Dunnett; R W Seiler
Journal:  Exp Brain Res       Date:  1996-11       Impact factor: 1.972

3.  Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease.

Authors:  D E Redmond; A Vinuela; J H Kordower; O Isacson
Journal:  Neurobiol Dis       Date:  2007-08-28       Impact factor: 5.996

4.  Primary dissociated cultures of human brainstem cells: a useful tool for their characterization and neuroprotection study.

Authors:  C Levallois; M C Calvet; J M Kamenka; D Petite; A Privat
Journal:  Cell Biol Toxicol       Date:  1995-08       Impact factor: 6.691

Review 5.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

6.  Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.

Authors:  Kimberly B Bjugstad; Yang D Teng; D Eugene Redmond; John D Elsworth; Robert H Roth; Shannon K Cornelius; Evan Y Snyder; John R Sladek
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

7.  Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease.

Authors:  Marcel M Daadi; Brad A Grueter; Robert C Malenka; D Eugene Redmond; Gary K Steinberg
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 8.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.